Despite nearly 20 years of availability, biosimilars show worldwide adoption rate of only 14% in initiative-tracked countries, while reference medicines still represent 86% of biologic
Approximately 60 to 78% of individuals diagnosed with Asthma also have concurrent Allergic Rhinitis
The increased drug load enabled by the nanoformed particles also allows smaller implants with sustained release properties to be developed.
The inspection closed with zero observations
Collaboration to accelerate and de-risk clinical development of Nanopharmaceutics CNS portfolio
The company will submit its comprehensive response on these observations to the US FDA
Economic analysis of cost of Vall d’Hebron University Hospital Stroke Unit shows direct-to-angio stroke pathway can save more than USD 3,000 per patient
The slogan for this year's World Blood Donor Day campaign is 'Give blood, give plasma, share life, share often'
Samsung Biologics will provide Pfizer with additional capacity for large-scale manufacturing for a multi-product biosimilars portfolio
Coverage of CGHS cities has expanded from 25 cities in 2014 to 80 in 2023
Subscribe To Our Newsletter & Stay Updated
